Although there was no statistical difference between CDO1 promoter methylation level to size of tumor (pT factor), lymph node metastasis (pN factor), UICC staging system, hormone receptor status, and Ki-67 status, but it tended toward with HER2 (p = 0.07) (S2 Fig). Here, ERBB2 is linked to neoplasm.